1. Home
  2. WAFD vs BCRX Comparison

WAFD vs BCRX Comparison

Compare WAFD & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WaFd Inc.

WAFD

WaFd Inc.

HOLD

Current Price

$35.18

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.88

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAFD
BCRX
Founded
1917
1986
Country
United States
United States
Employees
2037
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
WAFD
BCRX
Price
$35.18
$8.88
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$35.00
$20.82
AVG Volume (30 Days)
656.6K
4.2M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
3.05%
N/A
EPS Growth
N/A
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.15
$12.55
P/E Ratio
$11.49
$7.24
Revenue Growth
N/A
N/A
52 Week Low
$26.31
$6.00
52 Week High
$36.02
$11.31

Technical Indicators

Market Signals
Indicator
WAFD
BCRX
Relative Strength Index (RSI) 71.43 45.75
Support Level $31.67 $7.99
Resistance Level N/A $9.14
Average True Range (ATR) 0.73 0.36
MACD 0.29 -0.14
Stochastic Oscillator 80.56 22.18

Price Performance

Historical Comparison
WAFD
BCRX

About WAFD WaFd Inc.

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: